Humacyte (NASDAQ:HUMA) Receives New Coverage from Analysts at HC Wainwright
HC Wainwright assumed coverage on shares of Humacyte (NASDAQ:HUMA – Free Report) in a report issued on Monday morning, MarketBeat reports. The brokerage issued a buy rating and a $6.00 price target on the stock. HC Wainwright also issued estimates for Humacyte’s Q4 2023 earnings at ($0.25) EPS, FY2023 earnings at ($0.94) EPS, FY2024 earnings […]
More Stories
Royal Bank of Canada (NYSE:RY) Receives Consensus Rating of “Buy” from Analysts
Royal Bank of Canada (NYSE:RY – Get Free Report) (TSE:RY) has been assigned an average rating of “Buy” from the...
Sphere Entertainment Co. (NYSE:SPHR) Receives $45.83 Average PT from Brokerages
Sphere Entertainment Co. (NYSE:SPHR – Get Free Report) has earned a consensus recommendation of “Hold” from the eight brokerages that...
Trustmark Co. (NASDAQ:TRMK) Receives Consensus Recommendation of “Hold” from Brokerages
Shares of Trustmark Co. (NASDAQ:TRMK – Get Free Report) have earned an average rating of “Hold” from the four research...
Short Interest in Hong Kong Exchanges and Clearing Limited (OTCMKTS:HKXCY) Grows By 1,042.9%
Hong Kong Exchanges and Clearing Limited (OTCMKTS:HKXCY – Get Free Report) saw a significant growth in short interest in the...
Eguana Technologies Inc. (OTCMKTS:EGTYF) Short Interest Update
Eguana Technologies Inc. (OTCMKTS:EGTYF – Get Free Report) was the target of a significant increase in short interest during the...
Heidelberger Druckmaschinen Aktiengesellschaft (OTCMKTS:HBGRF) Short Interest Update
Heidelberger Druckmaschinen Aktiengesellschaft (OTCMKTS:HBGRF – Get Free Report) was the target of a large growth in short interest in the...